IAG Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
IAG Wealth Partners's PFE Position: Q2 2026 in Review
IAG Wealth Partners increased its Pfizer (PFE) stake by 0.71% in Q2 2026, buying an estimated $235 and bringing the position to 1,280 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #259.
IAG Wealth Partners first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $228K in Q1 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- IAG Wealth Partners held 1,280 shares of Pfizer worth $30.8K as of Q2 2026.
- IAG Wealth Partners bought 9 Pfizer shares in Q2 2026, an estimated $235.
- Pfizer made up ﹤0.01% of IAG Wealth Partners's portfolio in Q2 2026, its #259 holding.
- IAG Wealth Partners first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
- IAG Wealth Partners's Pfizer position peaked at $228K in Q1 2025.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on IAG Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.